Closing date: 15/11/2024
Non-Clinical Studentship Project: Investigation of the role of the small GTPase RAC1 in invasion and metastasis of Small Cell Lung Cancer
Lead Supervisors: Prof. Angeliki Malliri
Co-Supervisors: Dr Andrew Gilmore, Dr Kathryn Simpson, Dr Colin Lindsay, Prof. Caroline Dive
Applications Deadline: Friday 15th November 2024
Interviews: Friday 17th January 2025
Non-Clinical Studentship start date: September 2025
Project Keywords: Invasion, RAC1, SCLC
Research Opportunity: Non-Clinical Studentship leading to the award of PhD
Project Outline
Small cell lung cancer (SCLC) is an aggressive tumour, where 80% of patients have metastatic disease at diagnosis. Underlying this aggressiveness is intra-tumoural heterogeneity. Most SCLC tumours contain two different cell types, the majority being neuroendocrine (NE) with a small subset of non-neuroendocrine (non-NE). A phenotype switch from NE to non-NE generates the non-NE phenotype. Importantly, SCLC tumour heterogeneity is required for metastasis as co-operation between both cell types is needed.
The mechanistic understanding of NE to non-NE transition and its role in SCLC invasion and metastasis has been hindered by the lack of plasticity of established SCLC cell lines. However, we are fortunate to have access to patient circulating tumour cell-derived explant models which can undergo NE to non-NE transition. Using these, we have recently shown that the small GTPase RAC1 is highly active in non-NE cells and promotes NE to non-NE transition. RAC1 is a molecular switch, cycling between inactive GDP and active GTP-bound forms. Active RAC1 has established roles in stimulating migration/invasion of several cancer cells, but its role in migration/invasion and metastasis of SCLC is unknown.
Given the established roles of RAC1 in migration/invasion, its role in NE to non-NE transition and the requirement of both NE and non-NE cells for metastasis, this project aims to decipher the molecular and cellular mechanisms by which RAC1 signalling stimulates invasion and metastasis of SCLC both in vitro and in vivo. This project combines the expertise of the supervisory team in RAC1 signalling, matrix and SCLC biology with access to unique SCLC patient-derived models, presenting an unparalleled opportunity to uncover the mechanisms underpinning SCLC progression.
The supervisory environment is supportive and values inclusivity and diversity. The student will present their work internally and at scientific conferences and receive mentoring for successful career progression alongside valuable training in transferable skills.
Applications for this project are now open. Please complete your application on The University of Manchester website.
About Professor Angeliki Malliri (project Lead Supervisor)
Angeliki completed her bachelor’s degree in Biology at the University of Patras and obtained her PhD from the University of Crete, Greece. She worked as a postdoctoral scientist at the CRUK Beatson Institute (Glasgow) and Netherlands Cancer Institute (Amsterdam). She established her research group in 2004 at CRUK Manchester Institute and moved to Division of Cancer Sciences of the University of Manchester in March 2024. The main interest of her laboratory has been the mechanisms controlling and mediating cell migration and invasion, definitive characteristics of malignant cells essential for metastasis, focusing on KRas-mutant lung adenocarcinoma and small cell lung cancer.
Key information
Before submitting an application, please ensure you have read the information below about the funding arrangements and eligibility for Non-Clinical Studentships.
We also encourage you to get in contact with the lead supervisor to discuss the project and any particulars.
Further information is available on the Non-Clinical PhD Studentships webpage.
Our Non-Clinical PhD Studentships are usually funded for four years, with funding covering:
- Project running costs
- University tuition fees university tuition fees (at the UK rate, with some scholarships available for high-performing EU/International candidates)
- An annual stipend of £21,000 to help with living costs
Studentships are highly competitive and so we encourage you to contact any supervisors who you are interested in working with before applying for our Non- Clinical PhD Studentships.
International Candidates
The University of Manchester aims to support the most outstanding applicants from outside the UK.
We are able to offer a limited number of bursaries to high-performing EU and international candidates, covering PhD fees only. Bursaries do not include financial support for visa/health surcharges.
We assess each EU and international candidate’s suitability for a bursary at the application and interview stages.
You must hold, or be about to achieve, a First or Upper Second-class honours degree in a relevant subject. A related Master’s degree is also an advantage.
International applicants (including EU nationals) must ensure they meet the academic eligibility criteria (including English Language) before contacting potential supervisors to express an interest in their project. Eligibility information can be found on the University’s Country Specific information page.
Key dates
- Applications open: 11th October 2024
- Application deadline: 15th November 2024
- Interviews: 17th January 2025
- Start date: September 2025
Useful Links
Submit your application
Interested in applying for this opportunity? Go to The University of Manchester website to submit your application.
Non-Clinical PhD Studentships
Learn more about our Non-Clinical PhD Studentships.
Get in Touch
Contact Dr Georgina Binnie-Wright, Postgraduate Programme Manager.
Researcher Stories
Read first-hand experiences of from cancer scientists from across Manchester.
Why Manchester?
Find out why postgraduate students choose to study in Manchester.
A Day in the Life of a Non-Clinical PhD Student
Watch our short video to see what it's like to be a Non-Clinical PhD student in Manchester.